MENTOR, Ohio -- STERIS Corporation today announced that it has completed the decontamination of a United States Department of State mail processing facility located in Sterling, Va. using the company's proprietary technology and services. The building has now been re-opened for normal use following a very stringent environmental assessment of the facility, using approved Centers for Disease Control and Prevention (CDC) standards.
The 1.4-million-cubic-foot facility was contaminated with Bacillus anthracis spores (the causative agent of anthrax) after accepting mail that originated from the Brentwood, Washington, D.C. postal facility in October 2001. STERIS provided the decontamination technology and related support services through its subsidiary, Strategic Technologies Enterprises, Inc. This remediation program provided the opportunity for various governmental agencies to validate the STERIS proprietary VHP process for large-scale decontamination.
STERIS' decontamination technology was selected for use in this project after the Department of State's Technical Working Group (TWG) compared and evaluated available remediation technologies. The TWG included representatives from the State Department, the Environmental Protection Agency, CDC, Occupational Health and Safety Administration, Army Corps of Engineers, commonwealth of Virginia, and other local, state, and federal agencies. Evaluation criteria included efficacy, safety, materials compatibility and industry experience with the technology. The Company developed a comprehensive remedial decontamination plan and health and safety protocols that were deployed in the successful decontamination of the facility. As part of the decontamination plan, the Company supplied quality and sterility assurance protocols. STERIS' proprietary decontamination technology produces environmentally friendly by-products, namely water and oxygen, which were important criteria in the governmental selection process.
The technology used to decontaminate the facility is similar to technology STERIS has provided to pharmaceutical and research customers for more than a decade, modified by the company for application in large-scale, complex, building interiors. The technology has been proven effective at eliminating anthrax and other dangerous pathogens, and has been used previously to decontaminate facilities and other items by both government and industrial customers.
Source: STERIS Corporation
New UV-C Disinfection Technology for Ultrasound Probes Earns FDA Clearance
September 4th 2024Chronos, a chemical-free UV-C disinfection device for ultrasound probes, received FDA clearance. It offers health care professionals a fast, automated solution to reduce cross-contamination and improve infection prevention.
Addressing Sterile Processing Instrument Errors With Advanced Technology and Data Insights
September 3rd 2024Surgical instrument errors, often linked to visualization failures during sterile processing, pose significant risks to patient safety and OR efficiency. Advanced technologies, including AI, are essential for reducing these errors and improving overall outcomes in sterile processing departments.
Implementing FDA 21 CFR Part 820 & ISO 13485 on Quality System Regulation
August 30th 2024The FDA's 21 CFR Part 820 and ISO 13485 are crucial in regulating medical device quality systems. Harmonizing these standards by 2026 will streamline compliance, improve patient access to devices, and align US regulations with global practices.